FOI release

FOI 19/498 - advice on fibromyalgia and gabapentin

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/01030

Received 22 September 2025

Published 5 November 2025

Request

Can you please let me know in the UK is gabapentin licensed for usage in fibromyalgia, in reference to the Cochrane review below I appreciate it is in 2017 hence wondered if there was any updates Is there any new evidence or trials as the blow Cochrane review suggests very low quality evidence and it is very uncertain about estimates of benefit and harm because of a small amount of data from a single trial I would be grateful for your expert advice and opinion

Response

See attached

Documents

• FOI2025_01030 (redacted).pdf (554.4 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.